Mirae Asset Global Investments
SANA icon

Mirae Asset Global Investments’s Sana Biotechnology SANA Stock Holding History

Mirae Asset Global Investments’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.4K Sell
12,446
-1,448
-10% -$4.67K ﹤0.01% 1376
2026
Q1 		$40K Buy
13,894
+950
+7% +$3.74K ﹤0.01% 1330
2025
Q4 		$52.7K Buy
12,944
+2,943
+29% +$13.2K ﹤0.01% 1385
2025
Q3 		$35.5K Buy
10,001
+1,288
+15% +$4.66K ﹤0.01% 1400
2025
Q2 		$23.8K Buy
8,713
+1,242
+17% +$2.56K ﹤0.01% 1372
2025
Q1 		$12.8K Buy
7,471
+31
+0.4% +$87 ﹤0.01% 1445
2024
Q4 		$12K Sell
7,440
-606
-8% -$1.81K ﹤0.01% 1491
2024
Q3 		$34.4K Buy
8,046
+1,433
+22% +$7.53K ﹤0.01% 1363
2024
Q2 		$35.7K Sell
6,613
-50,922
-89% -$406K ﹤0.01% 1304
2024
Q1 		$328K Sell
57,535
-139,851
-71% -$1.05M ﹤0.01% 2071
2023
Q4 		$805K Buy
197,386
+146,303
+286% +$539K ﹤0.01% 1728
2023
Q3 		$198K Sell
51,083
-739
-1% -$3.97K ﹤0.01% 2304
2023
Q2 		$308K Sell
51,822
-4,359
-8% -$25.1K ﹤0.01% 2173
2023
Q1 		$184K Buy
56,181
+15,346
+38% +$61.3K ﹤0.01% 2350
2022
Q4 		$161K Buy
40,835
+79
+0.2% +$386 ﹤0.01% 2349
2022
Q3 		$244K Buy
40,756
+11,300
+38% +$81.5K ﹤0.01% 2254
2022
Q2 		$189K Buy
+29,456
New +$188K ﹤0.01% 2161

Other funds holding SANA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return

Mirae Asset Global Investments's SANA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Sana Biotechnology (SANA) stake by 10% in Q2 2026, selling an estimated $4.67K and leaving 12,446 shares worth $43.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1376.

Mirae Asset Global Investments first reported a position in SANA in Q2 2022 and has held it in 17 quarters since. The position peaked at $805K in Q4 2023. 74 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Mirae Asset Global Investments held 12,446 shares of Sana Biotechnology worth $43.4K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,448 Sana Biotechnology shares in Q2 2026, an estimated $4.67K.
  • Sana Biotechnology made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1376 holding.
  • Mirae Asset Global Investments first reported a position in Sana Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Sana Biotechnology position peaked at $805K in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.